MuSK-Associated Myasthenia Gravis: Clinical Features and Management

MuSK-Associated Myasthenia Gravis: Clinical Features and Management

Muscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG) is a rare, frequently more severe, subtype of MG with different pathogenesis, and peculiar clinical features. The prevalence varies among countries and ethnic groups, affecting 5–8% of all MG patients. MuSK-MG usually has an acute onset a...

Full description

Bibliographic Details
Main Authors: Carmelo Rodolico, Carmen Bonanno, Antonio Toscano, Giuseppe Vita
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Neurology
Subjects:
muscle-specific tyrosine kinase
atypical onset
tongue atrophy
MuSK-MG therapy
rituximab
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00660/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00660/full

Similar Items